Font: Financial Modeling Prep • Dec 17, 2025
Lennar Corporation (NYSE:LEN) is a leading home construction and real estate company in the United States, known for its affordable, move-up, and retirement homes. Competing with giants like D.R. Horton and PulteGroup, Lennar has established a strong presence in the market. Recently, RBC Capital set a price target of $95 for Lennar, while the stock was trading at $112.23, indicating a potential downside of about -15.35%.
On December 17, 2025, Lennar held its Q4 earnings call, featuring key executives like Co-CEOs Stuart Miller and Jonathan Jaffe, and CFO Diane Bessette. Analysts from top financial institutions, including UBS and Goldman Sachs, participated. The call provided insights into Lennar's financial performance and strategic direction, which are crucial for investors assessing the stock's future.
Lennar's stock, priced at $112.23, experienced a 4.54% drop, losing $5.34 in value. The stock fluctuated between $110.02 and $114.98 during the day. Over the past year, it reached a high of $148.11 and a low of $98.42. This volatility reflects the market's reaction to the company's performance and broader economic conditions.
Lennar's market capitalization stands at approximately $28.62 billion, with a trading volume of 9.41 million shares. This indicates significant investor interest and activity. The company's financial health and market position are key factors influencing its stock performance and investor sentiment.
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$4.95
-24.66%
|
|
ADTX§>
Aditxt, Inc.
|
$0.01
-30.81%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$4.27
-8.87%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$8.66
2.67%
|
|
TOVX§>
Theriva Biologics, Inc.
|
$0.32
29.36%
|
|
SMCI§>
Super Micro Computer, Inc.
|
$31.97
9.22%
|
|
HKIT§>
Hitek Global Inc.
|
$0.55
26.65%
|
|
PPCB§>
Propanc Biopharma, Inc.
|
$2.52
86.30%
|
|
INTC§>
Intel Corporation
|
$116.96
9.27%
|
|
RUBI§>
Rubico Inc.
|
$0.62
31.98%
|